Mal-NH-PEG10-CH2CH2COOPFP ester
Code | Size | Price |
---|
TAR-T18253-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T18253-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Mal-NH-PEG10-CH2CH2COOPFP ester is a polyethylene glycol (PEG)-based linker molecule employed in the synthesis of proteolysis targeting chimeras (PROTACs)[1].
CAS:
T18253
Molecular Weight:
846.79
Purity:
0.98
SMILES:
O=C(CCN1C(C=CC1=O)=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(OC2=C(F)C(F)=C(F)C(F)=C2F)=O
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.